Find Federal Grants
Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01)
National Institutes of Health · RFA-DA-17-013
Program Expansion Supplement: Supporting Laboratory Diagnosis and Monitoring to Scale up and Improve HIV/AIDS care and treatment in the Kingdom of Lesotho under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH15-15460201SUPP16
Food and Drug Administration · PAR-16-378
Program Expansion Supplement: Increasing Access to HIV Confidential Voluntary Counseling and Testing
Centers for Disease Control and Prevention · CDC-RFA-GH11-11550501SUPP16
Program Expansion Supplement: Increasing Access to HIV Confidential Voluntary Counseling and Testing and Enhancing HIV/AIDS Communications, Prevention and Care in the kingdom of Lesotho under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH11-11550501SUPP16
Program Expansion Supplement: Supporting Laboratory Diagnosis and Monitoring to Scale up and Improve
Centers for Disease Control and Prevention · CDC-RFA-GH15-15460201SUPP16
Indian Health Service · HHS-2016-IHS-NIHOE-3-HEALTH-REFORM-0001
Centers for Disease Control - NCHHSTP · CDC-RFA-PS15-150403CONT17
National Institutes of Health · RFA-AG-17-005
IAEA Project Surge Expansion of Sterile Insect Technique (SIT) to Control Mosquito Populations
Bureau of International Security-Nonproliferation · ISN-ISNIAEA-16-001
Limited Competition: Clinical Research Investigator Supplement (CRIS) for the Maternal Fetal Medicine Units (MFMU) Network and the Neonatal Research Network (NRN) (Admin Supp)
National Institutes of Health · PA-16-377
National Institutes of Health · PAR-16-376
National Institutes of Health · PAR-16-375
National Institutes of Health · RFA-ES-16-008
Predictors and Determinants of Age-Related Changes in Resiliencies to Physical Stressors in Humans (UH2/UH3)
National Institutes of Health · RFA-AG-17-014
Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01)
National Institutes of Health · PA-16-374
Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus-High Risk Local Areas
Centers for Disease Control - NCBDDD · CDC-RFA-DD16-1606
ONC FUNDING FOR CYBER THREAT INFORMATION SHARING IN THE HEALTH CARE AND PUBLIC HEALTH (HPH) SECTOR
Office of the National Coordinator · NAP-AX-16-006
National Institutes of Health · RFA-DK-16-022
Assistant Secretary for Preparedness and Response · EP-HIT-16-002